References
- Brasil. Datasus 2014. Acesso pelo site. Available from: http://www2.datasus.gov.br/DATASUS/index.php?area=0205&id=6936&VObj=http://tabnet.datasus.gov.br/cgi/deftohtm.exe?sinasc/cnv/nv.
- Crowley PA. Antenatal corticosteroid therapy: a meta-analysis of randomized trials, 1972 to 1994. Am J Obstet Ginecol. 1995;173(1):322–325.
- Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 1972;50(4):515–525.
- Wong D, Abdel-Latif M, Kent A. Antenatal steroid exposure and outcomes of very premature infants: a regional cohort study. Arch Dis Child Fetal Neonatal Ed. 2014;99(1):F12–F20.
- NIH Consensus development Panel of the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. Effects of corticosteroids for fetal maturation on perinatal outcomes. JAMA. 1995;273(5):413–418.
- Gyamfi C, Miele L, Wapner RJ, et al. The effect of plurality and obesity on betamethasone concentrations in women at risk for preterm delivery. Am J Obstet Gynecol. 2010;203(3):219e1–219e5.
- Roberts D, Brown J, Medley N, et al. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;8:CD012077.
- Ushida T, Kotani T, Sadachi R, Neonatal Research Network of Japan, et al. Antenatal corticosteroids and outcomes in preterm twins. Obstet Gynecol. 2020;135(6):1387–1397.
- Borges da Fonseca ESV. Manual de perinatologia. São Paulo: Federação Brasileira das Associações de Ginecologia e Obstetrícia, 2013.
- Ballard JL, Khoury JC, Wedig K, et al. New Ballard Score, expanded to include extremely premature infants. J Pediatr. 1991;119(3):417–423.
- Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978;187(1):1–7.
- Richardson DK, Corcoran JD, Escobar GJ, et al. SNAP-II and SNAPPE-II: simplified newborn illness severity and mortality risk scores. J Pediatr. 2001;138(1):92–100.
- Magann EF, Haram K, Ounpraseuth S, et al. Use of antenatal corticosteroids in special circumstances: a comprehensive review. Acta Obstet Gynecol Scand. 2017;96(4):395–409.
- Viteri OA, Blackwell SC, Chauhan SP, et al. Antenatal corticosteroids for the prevention of respiratory distress syndrome in premature twins. Obstet Gynecol. 2016;128(3):583–591.
- Murphy DJ, Caukwell S, Joels LA, et al. Cohort study of the neonatal outcome of twin pregnancies that were treated with prophylactic or rescue antenatal corticosteroids. Am J Obstet Gynecol. 2002;187(2):483–488.
- Blickstein I, Shinwell ES, Lusky A, et al. Plurality-dependent risk of respiratory distress syndrome among very-low-birth-weight infants and antepartum corticosteroid treatment. Am J Obstet Gynecol. 2005;192(2):360–364.
- Turrentine MA, Wilson PD, Wilkins IA. A retrospective analysis of the effect of antenatal steroid administration on the incidence of respiratory distress syndrome in preterm twin pregnancies. Am J Perinatol. 1996;13(6):351–354.
- Quist-Therson EC, Myhr TL, Ohlsson A. Antenatal steroids to prevent respiratory distress syndrome: multiple gestation as an effect modifier. Acta Obstet Gynecol Scand. 1999;78(5):388–392.
- Azad K, Costello A. Extreme caution is needed before scale-up of antenatal corticosteroids to reduce preterm deaths in low-income stings. Lancet Glob Health. 2014;2(4):e191-92–e192.
- Kuk JY, An JJ, Cha HH, et al. Optimal time interval between a single course of antenatal corticosteroids and delivery for reduction of respiratory distress syndrome in preterm twins. Am J Obstet Gynecol. 2013; 209(3):256–257.
- Chawla S, Lua J, Natarajan G, et al. Postnatal respiratory compliance among premature ventilated neonates associated with variable timing and dosing of antenatal steroids. Am J Perinatol. 2014;31(12):1073–1078.
- Melamed N, Shah J, Yoon EW, et al. The role of antenatal corticosteroids in twin pregnancies complicated by preterm birth. Am J Obstet Gynecol. 2016;215(4):482. e1.
- Boghossian NS, McDonald SA, Bell EF, et al. Association of antenatal corticosteroids with mortality, morbidity, and neurodevelopmental outcomes in extremely preterm multiple gestation infants. JAMA Pediatr. 2016;170(6):593–601.
- Blickstein I, Reichman B, Lusky A, et al. Plurality-dependent risk of severe intraventricular hemorrhage among very low birth weight infants and antepartum corticosteroid treatment. Am J Obstet Gynecol. 2006;194(5):1329–1333.
- Hashimoto LN, Hornung RW, Lindsell CJ, et al. Effects of antenatal glucocorticoids on outcomes of very low birth weight multifetal gestations. Am J Obstet Gynecol. 2002;187(3):804–810.
- Martinez FE, Linhares NJ, Ferlin ML. Antenatal use of corticosteroids and clinical evolution of preterm newborns. J Pediatr. 2004;80(4):277–278.
- Dalziel SR, Crowther AC, Harding JE. Antenatal corticosteroids 40 years on: we can do better. Lancet. 2014;384(9957):1829–1831.
- Jobe AH. Antenatal steroids in twins. Am J Obstet Gynecol. 2003;188(3):856.
- Palas D, Ehlinger V, Alberge C, et al. Efficacy of antenatal corticosteroids in preterm twins: the EPIPAGE-2 cohort study. BJOG. 2017; 125(9):1164–1170.
- Salem SY, Kibel M, Asztalos E, et al. Neonatal outcomes of low-risk, late-preterm twins compared with late-preterm singletons. Obstet Gynecol. 2017;130(3):582–590.
- Vaz A, Malheiro MF, Severo M, et al. Effect of antenatal corticosteroids on morbidity and mortality of preterm singletons and twins. J Matern Fetal Neonatal Med. 2018;31(6):754–760.